RBM10: Structure, functions, and associated diseases
- PMID: 33515724
- PMCID: PMC10445532
- DOI: 10.1016/j.gene.2021.145463
RBM10: Structure, functions, and associated diseases
Abstract
RBM10 is a nuclear RNA-binding protein (RBP) that regulates the alternative splicing of primary transcripts. Recently, research on RBM10 has become increasingly active owing to its clinical importance, as indicated by studies on RBM0 mutations that cause TARP syndrome, an X-linked congenital pleiotropic developmental anomaly, and various cancers such as lung adenocarcinoma in adults. Herein, the molecular biology of RBM10 and its significance in medicine are reviewed, focusing on the gene and protein structures of RBM10, its cell biology, molecular functions and regulation, relationship with the paralogous protein RBM5, and the mutations of RBM10 and their associated diseases. Finally, the challenges in future studies of RBM10 are discussed in the concluding remarks.
Keywords: Alternative splicing; Antithetical effects of RBM10; RBM10 mutations and diseases; RBM5; Regulation of RBM10; Splicing network; X-inactivation.
Copyright © 2021 The Author. Published by Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest
The author declares that he has no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
References
-
- Akimov V, B. -Hernandez I, Hansen SVF, Hallenborg P, Pedersen AK, Jensen B, D B, Puglia M, Christensen SDK, Vanselow JT, Nielsen MM, et al., 2018. UbiSite approach for comprehensive mapping of lysine and N-terminal ubiquitination sites. Nat. Struct. Mol. Biol. 25, 631–640. 10.1038/s41594-018-0084-y. - DOI - PubMed
-
- Antonello ZA, Hsu N, Bhasin M, Roti G, Joshi M, Van Hummelen P, Ye E, Lo AS, Karumanchi SA, Bryke CR, Nucera C, 2017. Vemurafenib-resistance via de novo RBM genes mutations and chromosome 5 aberrations is overcome by combined therapy with palbociclib in thyroid carcinoma with BRAFV600E. Oncotarget 8, 84743–84760. 10.18632/oncotarget.21262. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
